Zimmer Biomet Holdings (ZBH) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ZBH Analyst Ratings

Hold

5 Buy

11 Hold

1 Sell

Based on 17 analysts giving stock ratings to

Zimmer

Biomet Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ZBH Stock 12 Month Forecast

Average Price Target

CHF78.74

▲(4.99% Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is CHF78.74 with a high forecast of CHF88.51 and a low forecast of CHF66.78. The average price target represents a 4.99% change from the last price of CHF75.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"63":"CHF63","108":"CHF108","74.25":"CHF74.3","85.5":"CHF85.5","96.75":"CHF96.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":88.509817,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF88.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":78.7392527857143,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF78.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":66.7846801,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF66.78</span>\n  </div></div>","useHTML":true}}],"tickPositions":[63,74.25,85.5,96.75,108],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,69.5,70.96229361538461,72.42458723076923,73.88688084615384,75.34917446153847,76.81146807692308,78.27376169230769,79.73605530769231,81.19834892307692,82.66064253846153,84.12293615384615,85.58522976923076,87.04752338461539,{"y":88.509817,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,69.5,70.21071175274726,70.9214235054945,71.63213525824176,72.34284701098902,73.05355876373626,73.76427051648352,74.47498226923078,75.18569402197804,75.89640577472528,76.60711752747254,77.3178292802198,78.02854103296704,{"y":78.7392527857143,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,69.5,69.29112923846154,69.08225847692307,68.87338771538461,68.66451695384616,68.4556461923077,68.24677543076923,68.03790466923077,67.8290339076923,67.62016314615384,67.4112923846154,67.20242162307693,66.99355086153847,{"y":66.7846801,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":107.856,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.244,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.244,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.434,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.859,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.859,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.048,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.628,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.573,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.301,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.32,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.32,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF88.51

Average Price TargetCHF78.74

Lowest Price TargetCHF66.78

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Vijay Kumar

Evercore ISI

CHF96.56→CHF88.51

Buy

18.01%

Upside

Reiterated

07/06/26

Zimmer Biomet price target lowered to $110 from $120 at Evercore ISIZimmer Biomet price target lowered to $110 from $120 at Evercore ISI

Caitlin Roberts

Canaccord Genuity

CHF66.78

Hold

-10.95%

Downside

Reiterated

06/30/26

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Compass Therapeutics (NASDAQ: CMPX) and 10x Genomics (NASDAQ: TXG)

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

06/30/26

Analysts Offer Insights on Healthcare Companies: Tonix Pharma (NASDAQ: TNXP), Carlsmed, Inc. (NASDAQ: CARL) and Zimmer Biomet Holdings (NYSE: ZBH)

Mathew Blackman

TD Cowen

CHF87.71

Buy

16.94%

Upside

Reiterated

06/25/26

Analysts' Top Healthcare Picks: Codexis (CDXS), Zimmer Biomet Holdings (ZBH)

Travis Steed

Bank of America Securities

CHF80.46

Hold

7.28%

Upside

Reiterated

06/12/26

Zimmer Biomet Holdings (ZBH) Receives a Hold from Bank of America Securities

Larry Biegelsen

Wells Fargo

CHF72.42

Hold

-3.44%

Downside

Assigned

06/01/26

Wells Fargo Gives a Hold Rating to Zimmer Biomet Holdings (ZBH)

Joanne Wuensch

Citi

CHF76.44→CHF74.83

Hold

-0.23%

Downside

Reiterated

05/29/26

Zimmer Biomet price target lowered to $93 from $95 at CitiZimmer Biomet price target lowered to $93 from $95 at Citi

Steven Lichtman

William Blair

―

Hold

―

Reiterated

04/29/26

Zimmer Biomet: Hold Reiterated as Execution Risks, Salesforce Transition, and CFO Departure Offset Q1 Beat and Margin Upside

Jeff Johnson

Robert W. Baird

CHF80.46→CHF74.03

Hold

-1.30%

Downside

Reiterated

04/29/26

Zimmer Biomet price target lowered to $92 from $100 at BairdZimmer Biomet price target lowered to $92 from $100 at Baird

Richard Newitter

Truist Financial

CHF78.85→CHF74.03

Hold

-1.30%

Downside

Reiterated

04/29/26

Zimmer Biomet Holdings (ZBH) Receives a Hold from Truist Financial

Robbie Marcus

J.P. Morgan

CHF80.46→CHF76.44

Hold

1.92%

Upside

Reiterated

04/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Zimmer Biomet Holdings (NYSE: ZBH) and Qiagen (NYSE: QGEN)

Matt Miksic

Barclays

CHF80.46→CHF75.64

Sell

0.85%

Upside

Reiterated

04/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Radnet (NASDAQ: RDNT), Centene (NYSE: CNC) and Zimmer Biomet Holdings (NYSE: ZBH)

Rick Wise

Stifel Nicolaus

CHF88.51→CHF84.49

Buy

12.65%

Upside

Assigned

04/29/26

Stifel Nicolaus Sticks to Their Buy Rating for Zimmer Biomet Holdings (ZBH)

David Turkaly

Citizens JMP

CHF96.56→CHF84.49

Buy

12.65%

Upside

Reiterated

04/29/26

Zimmer Biomet price target lowered to $105 from $120 at CitizensZimmer Biomet price target lowered to $105 from $120 at Citizens

Michael Matson

Needham

―

Hold

―

Reiterated

04/28/26

Zimmer Biomet: Earnings Beat Masks Slowing Growth and Leadership Uncertainty, Supporting Hold Rating

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Vijay Kumar

Evercore ISI

CHF96.56→CHF88.51

Buy

18.01%

Upside

Reiterated

07/06/26

Zimmer Biomet price target lowered to $110 from $120 at Evercore ISIZimmer Biomet price target lowered to $110 from $120 at Evercore ISI

Caitlin Roberts

Canaccord Genuity

CHF66.78

Hold

-10.95%

Downside

Reiterated

06/30/26

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Compass Therapeutics (NASDAQ: CMPX) and 10x Genomics (NASDAQ: TXG)

Ryan Zimmerman

BTIG

―

Hold

―

Reiterated

06/30/26

Analysts Offer Insights on Healthcare Companies: Tonix Pharma (NASDAQ: TNXP), Carlsmed, Inc. (NASDAQ: CARL) and Zimmer Biomet Holdings (NYSE: ZBH)

Mathew Blackman

TD Cowen

CHF87.71

Buy

16.94%

Upside

Reiterated

06/25/26

Analysts' Top Healthcare Picks: Codexis (CDXS), Zimmer Biomet Holdings (ZBH)

Travis Steed

Bank of America Securities

CHF80.46

Hold

7.28%

Upside

Reiterated

06/12/26

Zimmer Biomet Holdings (ZBH) Receives a Hold from Bank of America Securities

Larry Biegelsen

Wells Fargo

CHF72.42

Hold

-3.44%

Downside

Assigned

06/01/26

Wells Fargo Gives a Hold Rating to Zimmer Biomet Holdings (ZBH)

Joanne Wuensch

Citi

CHF76.44→CHF74.83

Hold

-0.23%

Downside

Reiterated

05/29/26

Zimmer Biomet price target lowered to $93 from $95 at CitiZimmer Biomet price target lowered to $93 from $95 at Citi

Steven Lichtman

William Blair

―

Hold

―

Reiterated

04/29/26

Zimmer Biomet: Hold Reiterated as Execution Risks, Salesforce Transition, and CFO Departure Offset Q1 Beat and Margin Upside

Jeff Johnson

Robert W. Baird

CHF80.46→CHF74.03

Hold

-1.30%

Downside

Reiterated

04/29/26

Zimmer Biomet price target lowered to $92 from $100 at BairdZimmer Biomet price target lowered to $92 from $100 at Baird

Richard Newitter

Truist Financial

CHF78.85→CHF74.03

Hold

-1.30%

Downside

Reiterated

04/29/26

Zimmer Biomet Holdings (ZBH) Receives a Hold from Truist Financial

Robbie Marcus

J.P. Morgan

CHF80.46→CHF76.44

Hold

1.92%

Upside

Reiterated

04/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC), Zimmer Biomet Holdings (NYSE: ZBH) and Qiagen (NYSE: QGEN)

Matt Miksic

Barclays

CHF80.46→CHF75.64

Sell

0.85%

Upside

Reiterated

04/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Radnet (NASDAQ: RDNT), Centene (NYSE: CNC) and Zimmer Biomet Holdings (NYSE: ZBH)

Rick Wise

Stifel Nicolaus

CHF88.51→CHF84.49

Buy

12.65%

Upside

Assigned

04/29/26

Stifel Nicolaus Sticks to Their Buy Rating for Zimmer Biomet Holdings (ZBH)

David Turkaly

Citizens JMP

CHF96.56→CHF84.49

Buy

12.65%

Upside

Reiterated

04/29/26

Zimmer Biomet price target lowered to $105 from $120 at CitizensZimmer Biomet price target lowered to $105 from $120 at Citizens

Michael Matson

Needham

―

Hold

―

Reiterated

04/28/26

Zimmer Biomet: Earnings Beat Masks Slowing Growth and Leadership Uncertainty, Supporting Hold Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zimmer Biomet Holdings

3 Months

Danielle AntalffyUBS

Success Rate

12/17 ratings generated profit

Average Return

+0.91%

Copying Danielle Antalffy's trades and holding each position for 3 Months would result in 70.59% of your transactions generating a profit, with an average return of +0.91% per trade.

1 Year

Danielle AntalffyUBS

Success Rate

13/17 ratings generated profit

Average Return

+5.93%

Copying Danielle Antalffy's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +5.93% per trade.

2 Years

Danielle AntalffyUBS

Success Rate

15/17 ratings generated profit

Average Return

+11.42%

Copying Danielle Antalffy's trades and holding each position for 2 Years would result in 88.24% of your transactions generating a profit, with an average return of +11.42% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZBH Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ZBH has received 2 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. ZBH average Analyst price target in the past 3 months is 78.74.

Each month's total comprises the sum of three months' worth of ratings.

ZBH Financial Forecast

ZBH Earnings Forecast

Next quarter’s earnings estimate for ZBH is CHF1.62 with a range of CHF1.59 to CHF1.65. The previous quarter’s EPS was CHF1.68. ZBH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.

ZBH Sales Forecast

Next quarter’s sales forecast for ZBH is CHF1.72B with a range of CHF1.71B to CHF1.74B. The previous quarter’s sales results were CHF1.68B. ZBH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.

ZBH Stock Forecast FAQ

What is CH:ZBH’s average 12-month price target, according to analysts?

Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is 78.74.

What is CH:ZBH’s upside potential, based on the analysts’ average price target?

Zimmer Biomet Holdings has 4.99% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Zimmer Biomet Holdings a Buy, Sell or Hold?

Zimmer Biomet Holdings has a consensus rating of Hold, which is based on 5 buy ratings, 11 hold ratings and 1 sell ratings.

What is Zimmer Biomet Holdings’s share price target?

The average share price target for Zimmer Biomet Holdings is 78.74. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF88.51 ,and the lowest forecast is CHF66.78. The average share price target represents 4.99% Increase from the current price of CHF75.

What do analysts say about Zimmer Biomet Holdings?

Zimmer Biomet Holdings’s analyst rating consensus is a Hold. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of Zimmer Biomet Holdings?

To buy shares of CH:ZBH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Zimmer Biomet Holdings (ZBH) Stock Forecast & Price Target

ZBH Analyst Ratings

ZBH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Zimmer Biomet Holdings

ZBH Analyst Recommendation Trends

ZBH Financial Forecast

ZBH Earnings Forecast

ZBH Sales Forecast

ZBH Stock Forecast FAQ

Detailed List of Analyst Forecasts